Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Acuity Agrees to Acquire Parameter Technologies for $675 Million

Acuity Agrees to Acquire Parameter Technologies for $675 Million

Dow JonesDow Jones2026/10/26 13:24

By Adriano Marchese

Acuity has agreed to acquire Parameter Technologies for $675 million in cash, expanding its building-controls and environmental-monitoring footprint into data centers.

Upon closing, Parameter will be folded into Acuity's Distech Controls, part of the company's Acuity Intelligent Spaces reporting segment.

The deal pairs Parameter's leak detection, environmental monitoring and battery monitoring solutions for data centers and other critical infrastructure complementary with Distech's edge control platform.

Parameter expects to deliver sales of approximately $100 million for calendar 2027, representing growth of more than 30% year-over-year, and earnings before interest, taxes, depreciation and amortization margins of around 40%.

The acquisition, scheduled to close in the second quarter of 2027, is expected to be accretive to Acuity Intelligent Spaces revenue growth and margins.

Write to Adriano Marchese at adriano.marchese@wsj.com

(END) Dow Jones Newswires

October 26, 2026 09:24 ET (13:24 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading

CoreWeave (CRWV.US) bonds fell sharply on Wednesday, with some dropping to new lows.

智通财经•2026/11/05 01:51
CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading

AstraZeneca (AZN.US) reportedly receives a $10 billion acquisition offer! Shares of obesity drug developer Rhythm (RYTM.US) soar in response

According to three people familiar with the matter, AstraZeneca previously proposed to acquire obesity drug developer Rhythm Pharmaceuticals for approximately 10 billion dollars.

智通财经•2026/11/05 01:36

Goldman Sachs and Apollo in Talks to Sell 40 Billion-Dollar AI Chip Financing for SpaceX (SPCX.US), Market's Willingness to Take Over Faces Test

Goldman Sachs (GS.US) and Apollo Global Management (APO.US) are in talks with Wall Street investors to begin selling portions of a roughly $40 billion chip financing deal for SpaceX (SPCX.US).

智通财经•2026/11/05 01:07
Goldman Sachs and Apollo in Talks to Sell 40 Billion-Dollar AI Chip Financing for SpaceX (SPCX.US), Market's Willingness to Take Over Faces Test